ClinicalTrials.gg
DrugRead study by study

Giredestrant clinical trials

Also written GDC-9545 and RO7197597.

studies test it
22
open now
6
in phase 3
7
first study started
2017
ClinicalTrials.gov finds 30 studies for giredestrant. How that becomes 22 here

Every study that search finds has been read, to see whether and how it gives giredestrant. ClinicalTrials.gov counts as of Nov 16, 2026. How drug pages count

  1. 30Found by its intervention search · See all 30 hereIt also reads titles, arm labels, keywords and descriptions, and counts the drug’s other names. Of these, 30 name it in an intervention entry. The counts it shows beside each synonym overlap: a study writing two names counts under both.
  2. 30Give giredestrant to participants
  3. −1Observe patients on it, or give it outside a trial
  4. −7Give it beside what is tested
  5. 22Test it: the count on this site

Get an email when these change. Save the giredestrant studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Giredestrant
21

Development codes

GDC-9545
15
RO7197597
14
RG6171
14

Studies by the year they started

22 studies that test it; most in 2021 (5)

Studies that test giredestrant, by start year
YearStudies
20171
20191
20204
20215
20222
20233
20242
20252
20262

By phase

A phase 1/2 study counts in both.

Phase 1
6
Phase 2
11
Phase 3
7

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 17 · Other 5

Hoffmann-La Roche (11) · Genentech, Inc. (6) · MedSIR (2) · ETOP IBCSG Partners Foundation (1) · Alliance Foundation Trials, LLC. (1) · Fondazione Oncotech (1)

Often tested with

Tested in the same studies.

Inavolisib (5) · Ipatasertib (3) · Ado-Trastuzumab Emtansine (2) · Atezolizumab (2) · Bevacizumab (2) · Cobimetinib (1) · Paclitaxel (1) · Olaparib (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

New treatments tested with it · 8 most studied

New when their studies opened, with giredestrant beside them; studies of each.

Reaching primary completion within a year · 2

Studies that test giredestrant.

Studies

Open first, then newest update. How each study uses giredestrant has had a first review, but it may not be perfect: check the study record before relying on it for anything important, and report a problem from its row. Some give it without naming it in an intervention entry: those were found by reading the record.

Testing it · 22

See all 22 studies that test giredestrant →

Tested on its own · 5 — no other medicine in its arm
Tested with established drugs · 10 — they are given beside it
Tested in a combination · 7 — another drug in the study is under test too
Beside a new treatment under test · 6 — a new drug, cell therapy or vaccine is what the study tests

New treatments tested with giredestrant: atirmociclib 3 · ipatasertib 1 · SGN-LIV1A 1 · selicrelumab 1 · sacituzumab govitecan 1 · inavolisib 1 · Vustanaciclib 1 · GDC-0587 1

Given beside what is tested · 1 — usual care or a partner of the new treatment
Observed · 1 — patients on it are followed, or it is given outside a trial

Codes

What other systems call giredestrant · ClinicalTrials.gg INT001743

  • MeSH (NLM) C000720132giredestrantConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 28P3DU6DB3GIREDESTRANTConfirmed FDA, NLM
  • NCI Thesaurus C147030GiredestrantOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.

Start the discussion